Y. Song, MD, ScD, “Clinical Usefulness of High-Sensitivity C-Reactive Protein in Predicting Risk of the Metabolic Syndrome: Epidemiologic Evidence”, N A J Med Sci, vol. 1, no. 1, Jan. 2008.